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Background: Human enterovirus type 71 (EV71) and Coxsackievirus A group type 16 (CA16) belong to human
Enterovirus species A of the family Picornaviridae. These viruses are recognized as the major pathogens responsible
for epidemics of hand-foot-mouth disease (HFMD), which presents with fever and vesicular eruptions of palms,
soles of the feet or mouth. Human scavenger receptor class B, member 2 (SCARB2) has been identified as the
receptor for both EV71 and CA16, as overexpression of SCARB2 in cells can enhance virus replication significantly.
Methods: In this study, we used a lentivirus packaging vector to transduce the SCARB2 gene into human
embryonic kidney cells (293), human rhabdomyosarcoma cells (RD) and African green monkey kidney cells (Vero) to
create stable expression lines. Expression of SCARB2 in the resulting three transgenic cell lines was confirmed by
real-time RT-PCR, immunofluorescence and flow cytometry.
Results: Levels of SCARB2 mRNA determined by real-time RT-PCR in 293-SCARB2 (293S) or RD-SCARB2 (RDS)
transgenic cell lines were approximately 2 × 102 times higher than those in 293 and RD cells, respectively, and three
times higher in Vero-SCARB2 (VeroS) than in Vero cells. Furthermore, EV71 and CA16 virus titers in 293S and RDS
cells were 102–103-fold higher (detected in RD cell) than those in the parental cells, and a 10-fold higher titer of
EV71 was achieved in VeroS cells compared with that in Vero cells.
Conclusions: We established for the first time three cell lines stably overexpressing SCARB2, which showed drastic
increases in susceptibility to EV71/CA16 infection. These optimal cell lines may be utilized to develop inactivated
vaccines for EV71/CA16 and facilitate rapid detection and isolation of HFMD pathogens or other Enterovirus
serotypes. Furthermore, these stable cell lines also can serve as tools to facilitate drug screenings as well as
molecular studies on virus-host interactions and pathogenesis of causative agents for HFMD.
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EV71 and CA16, both belonging to human Enterovirus
species A of the Enterovirus genus within the family
Picornaviridae, are recognized as major pathogens respon-
sible for hand-foot-mouth disease (HFMD) epidemics [1,2].
Although HFMD generally produces mild exanthems, in-
fections involving EV71 can progress to severe neurological* Correspondence: weikong@jlu.edu.cn; jiangcl@jlu.edu.cn
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reproduction in any medium, provided the ordisease, including fatal encephalitis, aseptic meningitis and
acute flaccid paralysis [3-7]. Neurological complications of
EV71 infection also may occasionally cause permanent
paralysis or death. The first case of HFMD was reported
in the United States in 1969 [8]. Subsequent epidemics
and sporadic outbreaks of HFMD have been reported in
China, Malaysia and many other countries, especially in
Asia [9]. Thus, HFMD has become a considerable public
health concern worldwide.
Effective antiviral agents and vaccines against EV71 or
CA16 are currently unavailable [10,11]. In addition, rapid
and low-cost diagnostic methods for identifying infectionshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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also needed [12,13]. Virus isolation and conventional
assays, such as neutralization assays and RT-PCR, for
viral RNA detection and diagnosis of EV71/CA16 are
time-consuming and labor-intensive [14-16]. Although
cell culture is most widely used in laboratory diagnosis
and to identify different serotypes in preclinical studies,
there are no optimal cells lines which are susceptible to
the major pathogens of HFMD. Therefore, choosing or
establishing an ideal cell line is essential for improving
virus isolation and propagation methods for vaccine
development.
Recently, an inactivated EV71 vaccine made from Vero
or KMB-17 cells was developed [17-20]; however, the
virus titer did not reach high levels in these cell lines.
Specific cell surface receptors are important for permit-
ting infection of many viruses. Two membrane proteins
have been identified as cellular receptors of EV71 and
CA16, human P-selectin glycoprotein ligand-1 (PSGL-1)
[21] and human scavenger receptor class B, member 2
(SCARB2) [22]. SCARB2, also called lysosomal integral
membrane protein 2 (LIMP-2), lysosomal membrane
glycoprotein-85 (LGP85) or CD36b like-2, has two trans-
membrane domains with the N and C termini located in
the cytosol and traverses the membrane twice. Expressed
in many tissues, SCARB2 is proposed to be the receptor
for the selective uptake, degradation of cytosolic proteins
by lysosomes [23] and endosomal/lysosomal compart-
ments [24]. In addition, overexpression of SCARB2 in
L929 cells has been demonstrated to increase the titer
of EV71/CA16 strains [22,25-27].
Furthermore, previous reports have shown that transient
overexpression of SCARB2 in cells which naturally lack
or express low levels of this receptor can yield higher
virus titers of EV71 and CA16 [22]. RD and Vero cell lines
have been most widely used for culture of most enterovi-
ruses [12,18], and CA16 virus titers in 293 cells are gener-
ally higher than those in other cells, such as Vero and
A549 cells (previously observed in our lab). Therefore, in
this study, SCARB2 gene was introduced into 293, RD and
Vero cells separately via a lentiviral expression vector and
the susceptibility of stable SCARB2-overexpressing cells
to infection by EV71 and CA16 would be significantly
enhanced compared with the parental cells.
Results
Establishment of cell lines stably expressing SCARB2
To establish cell lines stably expressing a high level of
SCARB2, the 293, RD and Vero cell lines were trans-
duced with a lentivirus carrying the SCARB2 gene, and
lentivirus production was detected in the supernatant.
Positive colonies were selected in the presence of puro-
mycin and sub-cloned three times. After selection, at
least 10 puromycin-resistant cell colonies were screened,and two clones expressing the highest levels of SCARB2
were selected for subsequent experiments (data of one
clone shown). Compared with the parental cells, SCARB2
expression in the cell lines detected every five passages
showed a higher SCARB2 expression by real-time RT-
PCR and flow cytometry (data not shown). Furthermore,
the size and form of the stable SCARB2-expressing cells
appeared similar to those of the original cell lines, except
for RDS cells which exhibited a plumper polygonal cell
morphology compared with RD cells (data not shown).
Analysis of stable cell lines
Real-time RT-PCR was used to examine the relative ex-
pression of SCARB2 transcripts. The transgenic cell lines
were able to stably express up to 2 × 102-fold higher
levels of the SCARB2 mRNA compared to the original
cell lines (Figure 1a). Western blot analysis using an
anti-SCARB2 antibody indicated that SCARB2 protein
levels in 293S, RDS and VeroS cells were obviously
higher than those expressed at basal levels in the paren-
tal cells (Figure 1b). Among the three stable cell lines,
293S and RDS evidently expressed the highest amounts
of SCARB2 at both the transcriptional and protein
levels, which was confirmed concurrently by flow cy-
tometry analysis (Figure 1c). Altogether, these results
indicated that the 293S, RDS and VeroS cells stably
expressed SCARB2 on the cell surface after screening
and selection, with 293S and RDS showing the highest
levels of the receptor.
Localization of SCARB2
To determine the localization of SCARB2 in 293S, RDS
and VeroS cells, we monitored the receptor expression
by confocal microscopy. Cell surface expression of SCARB2
was clearly observed on all three transgenic cells. Every
cell line was permeabilized (P-cell) by Triton-100 or not
and stained using a suboptimal concentration of anti-
body that did not stain the endogenous SCARB2 on the
cell membrane of the three parental cell lines. As shown
in Figure 2, SCARB2 was more dispersed in the cyto-
plasm of cells treated with Triton-100, while SCARB2
was observed at the cell membrane when the cells were
not permeabilized. These data confirmed that SCARB2
was localized to the surface membrane in the three
transgenic cell lines.
Characterization of SCARB2 stable cell lines
Infectibility of the stable transgenic cell lines was com-
pared with that of the original cells using EV71 and CA16
pseudoviruses and wild-type viruses. First, twelve geno-
types of EV71 pseudovirus and four genotypes of CA16
pseudovirus carrying the luciferase reporter gene were
used to infect the six cell lines. Luciferase measurements
indicated that all of the pseudoviruses produced higher
Figure 1 Detection of SCARB2 expression in SCARB2-overexpressing and parental cells. (a) Relative SCARB2 mRNA level was detected by
real-time RT-PCR with β-actin as the internal control. (b) SCARB2 protein of six cells was detected by Western blot using an anti-SCARB2 antibody.
(c) Cell surface expression of SCARB2 in six cells. Three parental cells were stained with an anti-SCARB2 antibody (solid lines), SCARB2 cells were
stained with an anti-SCARB2 antibody (grey region) or a secondary antibody alone (dotted lines) and analyzed by flow cytometry.
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(Figure 3). Almost all EV71 and CA16 pseudoviruses
showed 102–104-fold higher titers in 293S and RDS cells
than those in the parental cells, while no significant
differences in titers, except for the slightly higher level
of EV71-B3, were observed in VeroS versus Vero cells.
Concurrently, the six cell lines were infected with EV71
and CA16 viruses expressing the EGFP reporter protein.
Subsequent analysis showed higher levels of EGFP protein
in 293S and RDS cells than in 293 and RD cells, respect-
ively. However, no significant difference in the level of
EV71-EGFP or CA16-EGFP was found between infected
VeroS and Vero cells (Figure 4). These results demon-
strated that 293S and RDS were more sensitive than
parental cells to infection of EV71 or CA16.
Replication kinetics
To assess the efficiency of virus infection in SCARB2-
overexpressing and parental cells, EV71 and CA16 wild-
type viruses were used to infect the six cell lines, which
were harvested at 12, 24, 48 and 72 h after infection.
The growth kinetics of EV71 and CA16 were determined
by titration in RD cells (CCID50) and real-time RT-PCR.
As shown in Figure 5a and 5b, EV71 and CA16 virus ti-
ters in 293S and RDS cells were 102–103-fold higher
than those in the parental cells, and a 10-fold higher
titer of EV71 was achieved in VeroS cells compared
with that in Vero cells. Meanwhile, the CCID50 valuesof EV71 and CA16 virus collected at 24 and 48 h post-
infection (hpi) from these six cell lines were dramatic-
ally elevated in both 293S and RDS, consistent with the
real-time RT-PCR results. However, EV71 was reduced
as determined by CCID50 titer but not by real-time RT-PCR
at 72 hpi, while CA16 was still elevated by both measures
at that time. Additionally, observations at 48 h after EV71
and CA16 infection in the six cell lines showed that the
CPE in the transgenic cells initiated earlier and in-
creased more evidently and rapidly than in parental cells
(Figure 5c and 5d). As with the results above, there were
still no significant differences in CCID50 and viral
mRNA of CA16 between Vero and VeroS cells. These
results indicated that EV71 and CA16 could enter and
propagate in the SCARB2 transgenic cells and spread
efficiently and rapidly.
Discussion
As major causative pathogens of HFMD epidemics, EV71
and CA16 can lead to severe neurological disease. No
effective antiviral agents or vaccines against EV71 and
CA16 or rapid and low-cost diagnostic methods for these
viruses are currently available. Conventional detection
and isolation methods for HFMD pathogens from clin-
ical samples involve co-culture with cell lines such as
RD, A549 and BGMK cells, followed by RT-PCR or CPE
examination. Rapid detection of pathogens depends on
the selection of cell lines, and RD cells had been the
Figure 2 Localization of SCARB2. Cells were fixed and stained with a SCARB2-specific antibody (green) at a suboptimal concentration that did
not detect endogenous SCARB2 proteins in the cell membrane of the three parental cell lines. Nuclei were stained with DAPI (blue). The three
stable cell lines were treated with (P-cell) or without Triton-100 to permeabilize the cell membrane.
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Although the titers were not high, an inactivated EV71
vaccine has been generated from Vero or KMB-17 cells
[17-20]. The Vero cell line is also the most widely ac-
cepted continuous cell line by regulatory authorities and
has been used for the production of polio and H5N1
inactivated whole-virus vaccines [33]. Meanwhile, highCA16 virus titers have been achieved with 293 cells
(previously observed in our lab).
Based on the reasons above, we selected the 293, RD
and Vero cell lines to prepare transgenic cell lines ex-
pressing SCARB2, one of the known receptors of HFMD
pathogens that are widely expressed in different cells
and tissues. As the overexpression of SCARB2 in L929
Figure 3 Infectivity of EV71 and CA16 pseudoviruses in SCARB2-overexpressing and parental cells. Twelve serotypes of EV71 pseudoviruses
and four serotypes of CA16 pseudoviruses with the luciferase reporter gene were used to infect 293 and 293S cells (a), RD and RDS cells (b), Vero and
VeroS cells (c).
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Figure 4 Detection of EV71-EGFP and CA16-EGFP virus in infected cells. The six cells were infected with the EV71-EGFP (a) or CA16-EGFP
(b) virus, and images were acquired using a fluorescence microscope after incubation for 48 h.
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yield higher virus titers [22], we reasoned that SCARB2
expression in 293, RD and Vero cells should also facilitate
infectivity and propagation of HFMD pathogens. The
transgenic cell lines were generated using a lentivirus-
based vector, a method which is widely used for inserting
a gene of interest into cells or animals for research or into
organs for human transplantation [34-37]. In this study,
we used the Lenti-X Plvx-puro vector for packaging
lentiviruses with the VSV-G envelope, which allows
transduction of almost all mammalian cells [38], to gen-
erate the SCARB2 stable cell lines. Monitoring of the
transduced cell lines by real-time RT-PCR and flow cy-
tometry every five passages showed that SCARB2 was
stably overexpressed for up to 50 passages (data not
shown). 293S and RDS showed the greatest increases of
SCARB2 mRNA levels (>200-fold) and titers of EV71
and CA16 (>103-fold), compared with parental cells.
EV71 achieved an especially high titer in 293S that was
107-fold higher than that in 293 cells. Meanwhile, VeroS
cells produced only 10-fold higher virus titers com-
pared with Vero cells, which was consistent with its
lower expression of SCARB2 relative to that of 293S
or RDS cells.Some distinguishing characteristics were observed be-
tween the propagation of EV71 and CA16 in the stable
cell lines. First, the EV71 virus titer was 10 ~ 100-fold
higher than that of CA16 when used to infect 293S or
RDS cells separately, and this difference was 10-fold in
VeroS cells. These results imply that EV71 is more
sensitive to SCARB2 and better utilizes this protein re-
ceptor than CA16. However, there was a dramatic 107-fold
elevation in the titer of wild-type EV71 virus (EV71-C4b),
while the EV71 pseudovirus (also EV71-C4b) generated a
103-fold higher titer in 293S cells than in 293 cells. The
lower increase in titer seen with the EV71 pseudovirus
could be explained by the fact that it undergoes a single
round of infection, while the wild-type virus replicates mul-
tiple times before detection.
Examination of viral growth kinetics by measuring CCID50
revealed that virus attachment in the first step of infection
(primary infection) and replication of EV71 and CA16
were more efficient when cells overexpressed the SCARB2
protein. More obvious differences of viral mRNA were
detected than those found by observing CPE in RDS
cells due to the greater sensitivity of real-time RT-PCR.
However, viral replication was affected in cells displaying
CPE over a long period of time (beyond 12–24 hpi), and
Figure 5 Viral growth kinetics in SCARB2-overexpressing and parental cells. Viral growth kinetics of EV71 (a) and CA16 (b) were detected
by determination of CCID50 in RD cells and real-time RT-PCR. (c, d) Images of CPE were acquired at 48 h after wild-type EV71 and CA16 infection
in the six cell lines.
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phenomenon is similar to that reported by Yamayoshi
et al. [22]. Taken together, the results suggest that these
stable cell lines may support increased rates of infection
and replication of EV71 and CA16.
In summary, we successfully established three transgenic
cell lines using a lentivirus system to stably overexpress the
human SCARB2 protein on the surface of 293, RD and
Vero cells. The SCARB2-overexpressing cells will facilitate
more rapid detection and isolation of the major pathogens
of HFMD, as well as other serotypes of enteroviruses such
as CA7 and CA14 which share the SCARB2 receptor [26].
Conclusion
In this study, we established for the first time three cell
lines with increased susceptibility to EV71/CA16 by stable
overexpression of SCARB2, in which EV71 and CA16




Human embryonic kidney (HEK 293), human rhabdo-
myosarcoma (RD), African green monkey kidney (Vero)
and 293T cells were obtained from the American Type
Culture Collection (ATCC) and maintained in Dulbecco’s
modified Eagle medium (DMEM) (Sigma) supplemented
with 10% fetal bovine serum (FBS) (10% FBS-DMEM).
Cells were maintained at 37°C with 5% CO2. The stable
cell lines 293-SCARB2 (293S), RD-SCARB2 (RDS) and
Vero-SCARB2 (VeroS) were cultured in 10% FBS-DMEM
supplemented with puromycin (293S: 1.25 μg/ml, RDS:
0.5 μg/ml, VeroS: 4.0 μg/ml; Clontech).
Viruses
Wild-type viruses
EV71 and CA16 were isolated from a patient in Anhui
(EV71-C4b) and Taiwan (CA16-B1a), respectively, during
the HFMD epidemic in China, 2010. Both viruses were
propagated in RDS cells. The culture supernatants were
harvested 3 days post-infection, passed through a 0.45 μm
filter to remove cellular debris and aliquotted for storage
at −80°C as viral stocks.
EV71 and CA16 pseudoviruses
EV71 and CA16 pseudoviral vectors (CVA16-A: U05876.1,
CVA16-B1a: AF177911.1, CVA16-B1b: EU262658.1, CVA16-
B2: AY895127.1, EV71-B1: AB482183.1, EV71-B2: U22522,
EV71-B3: AM396586, EV71-B4: AF316321, EV71-B5:
EU527985, EV71-C1: DQ452074, EV71-C2: AF176044,
EV71-C2L: HM622392.1, EV71-C3: DQ341356.1, EV71-
C4a: AY895132.1, EV71-C4b: EU703814.1, EV71-C5:
EF063152) (previously generated in our lab) were con-
structed by replacing the P1 gene with a firefly luciferasereporter gene in the genome and inserting a CMV pro-
moter at the 5′-end for transcription in vitro. 293T cells
were transfected with the pcDNA3.1-T7 RNA polymerase
expression plasmid, pT7-EV71/CA16-luc replicon plasmid
and EV71 capsid expression plasmid using Lipofectamine
2000 (Invitrogen). EV71/CA16-pseudoviruses were col-
lected 48 h post-transfection by two rounds of freeze-
thaw cycles and then aliquot and stored at −80°C as
viral stocks.
EV71-EGFP and CA16-EGFP viruses
Replication competent EV71 and CA16 with the EGFP re-
porter gene, EV71-EGFP and CA16-EGFP virus (respectively
derived from EV71-C3, a gift kindly provided by Liguo
Zhang at the Institute of Biophysics, Chinese Academy
of Sciences, and from CA16-B1a, previously generated
in our lab), were generated in 293S and RDS cells. The
coding sequence of EGFP was inserted between the
5′UTR and VP4. 293T cells were transfected with EV71-
EGFP and CA16-EGFP vectors using Lipofectamine 2000.
Viruses propagated in 293S and RDS were collected
after two rounds of freeze-thaw cycles, passed through a
0.45 μm filter to remove cellular debris, aliquotted and
stored at −80°C as viral stocks.
Establishment of cell lines
Lentivirus production from Lenti-X vector
The coding sequence of the human SCARB2 gene was
inserted into the Lenti-X pLVX-Puro vector (Clontech)
with EcoR I and Xba I sites. For production of the lenti-
virus particles, 293T cells were transfected with the plas-
mid following the manual. The cell culture supernatant
was harvested 72 h after transfection, passed through a
0.45 μm filter and centrifuged in 4000 × g for 5 min to re-
move cellular debris. Lentivirus production was detected
in the supernatant using an anti-p24 monoclonal antibody
(data not shown) before storage at −80°C.
Establishment of stable transgenic cell lines
The three parental cell lines (293, RD, Vero cells) were
infected with the lentivirus carrying the SCARB2 trans-
gene. After 48 h of incubation, cells were passaged three
times with 10% FBS-DMEM containing puromycin at a
pre-determined dosage. The positively screened cell lines
were sub-cloned three times by limiting dilution, and gene
expression was detected every fifth passage via real-time
RT-PCR and flow cytometry.
Analysis of stable transgenic cell lines
Real-time RT-PCR
To detect the relative SCARB2 expression at the gene
level, mRNA was extracted from the six cell lines with
the QIAamp RNeasy MiniKit separately according to
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scription was performed with TAKARA Reverse Tran-
scriptase XL. PCR was carried out using the following
primers: SF: 5′-GTACTGAGGCATTTGACTCCT-3′,
SR: 5′-AGTTCCCTGTAGGTGTATGGC-3′. The real-
time RT-PCR cycling program involved an initial denatur-
ation step at 95°C for 2 min, followed by 40 cycles of 15 s
at 95°C and 30 s at 60°C. Fluorescence data were collected
during each annealing-extension step, and the relative
SCARB2 mRNA levels were analyzed with β-actin as the
internal control using the Bio-Rad CFX96 software.
Western blot
Expression levels of SCARB2 in the positive cell lines
were assessed by Western blot with tubulin as the
internal control. After treatment with lysis buffer, cell
lysates were subjected to SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE). Following electrophoresis, the
resolved proteins were transferred onto a nitrocellulose
membrane and blocked with 5% evaporated milk for 15 min
at 37°C. The membrane was then incubated with an anti-
SCARB2 antibody (diluted 1:1000, Abnova: PAB13673) for
45 min at room temperature, followed by incubation with
an alkaline phosphatase (AP)-conjugated rabbit anti-goat
secondary antibody at a dilution of 1:1000. After 30 min
of incubation at room temperature, staining was carried
out with NBT and BCIP solutions.
Flow cytometry
Cells were harvested using trypsin-EDTA, which was neu-
tralized with FBS-containing culture medium. The cells
were pelleted and incubated with the SCARB2-specific
antibody (diluted 1:100, Abnova: H00000950-M01) in PBS
containing 1% BSA at room temperature for 30 min,
followed by incubation with FITC-conjugated goat anti-
mouse IgG. SCARB2 protein on the cell surface was
detected on a Beckman flow cytometer. The fluorescence
intensity was determined after deducting the background
staining with the secondary antibody alone.
Localization of SCARB2
Cells which are susceptible to infection often express
virus receptor proteins at the cell membrane. We detected
the localization of SCARB2 using laser confocal micros-
copy. Generally, 293S, RDS and VeroS cells were cultured
on microscope slides for 24 h before fixation with 4%
paraformaldehyde for 10 min at room temperature. For
each transgenic cell line, one slide was permeabilized with
0.25% Triton-100 for 8 min at room temperature, while
another slide was not treated. After exposure of the slides
to the primary anti-SCARB2 antibody overnight at 4°C,
a FITC-conjugated goat anti-mouse antibody was
used as the secondary antibody (diluted 1:100) to stain
cells at room temperature for 45 min in a darkroom.Subsequently, the microscope slides were mounted with
coverslips and 50% glycerol. Images were acquired using
a fluorescence microscope.
Characterization of stable transgenic cell lines
EV71 and CA16 pseudovirus infection
To compare the susceptibility to virus infection of the
stable transgenic cell lines with that of the original cells,
EV71 and CA16 pseudoviruses containing a luciferase
reporter gene were used to infect the six cell lines. Cells
(104/well) were seeded in 96-well plates for approxi-
mately 12 h before infection. Various EV71 and CA16
pseudoviruses were applied to cells at 200 cell culture
50% infectious doses (CCID50)/well. The firefly luciferase
activity was measured after 24 h of incubation using
Thermo Fluoroskan Ascent FL [32].
EV71-EGFP and CA16-EGFP virus infection
Replication-competent EV71 and CA16 with an EGFP
reporter gene were generated with the C3 and B1a infec-
tious clones, respectively, by transfection of 293T cells
using Lipofectamine 2000. EV71-EGFP and CA16-EGFP
viruses were collected 48 h later and immediately co-
cultured with 293S and RDS cell lines. The six cells
(106/well) were seeded in 6-well plates approximately 12 h
before infection, and then viruses were added to the wells
at the multiplicity of infection (MOI) of 0.01. After in-
cubation for 48 h, images were acquired using a fluores-
cence microscope.
Replication kinetics
To examine viral growth kinetics, we infected the six cell
lines (three transgenic and three parental cell lines) with
wild-type virus (EV71-C4b or CA16-B1a) at an MOI≈ 0.001.
After incubation for 12, 24, 48 or 72 h, the viruses were
harvested separately and frozen at −80°C until use. There-
after, RD cells (104/well) were seeded in a 96-well plate,
and the viruses collected above were serially diluted
10-fold in DMEM with 2% FBS and added to the wells
in 10 parallel sets. After incubation for 72 h, the CCID50
was calculated via the Reed-Muench method by deter-
mining the number of wells with CPE. The viral kinetics
was formulated using the CCID50 of the six cell lines.
To examine EV71 and CA16 viral growth kinetics in
the gene level, viruses collected at the four time points
from the six cell lines were measured using real-time
RT-PCR [39]. The viruses were purified prior to the real-
time RT-PCR analysis. Briefly, the infected cells were lysed
by three rounds of freezing and thawing. The resultant
lysates were filtered through a 0.22-μm filter. Viruses
were then purified from the resultant suspension by
centrifugation at 28,000 rpm for 4 h in a Beckman SW40
rotor. Thereafter, the viral mRNA was extracted from
those purified virus stocks with the QIAamp Viral RNA
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instructions (QIAGEN), and reverse transcription was
performed with TAKARA Reverse Transcriptase XL.
PCR to detect EV71 and CA16 was carried out using
the following primers: VF (5′UTR: 445–459 bp): 5′-
TCCTCCGGCCCCTGA-3′, VR (5′UTR: 580–600 bp):
5′-AATTGTCACCATAAGCAGCCA-3′. The cycling pro-
gram involved an initial denaturation step at 95°C for
2 min, followed by 40 cycles of 15 s at 95°C and 30 s
at 60°C. Fluorescence data were collected during each
annealing-extension step and analyzed using the Bio-
Rad CFX96 software.
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